Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis

Glioblastoma (GBM) remains uniformly lethal, and despite a large accumulation of immune cells in the microenvironment, there is limited antitumor immune response. To overcome these challenges, a comprehensive understanding of GBM systemic immune response during disease progression is required. Here,...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:JCI Insight
المؤلفون الرئيسيون: Alban, Tyler J., Alvarado, Alvaro G., Sorensen, Mia D., Bayik, Defne, Volovetz, Josephine, Serbinowski, Emily, Mulkearns-Hubert, Erin E., Sinyuk, Maksim, Hale, James S., Onzi, Giovana R., McGraw, Mary, Huang, Pengjing, Grabowski, Matthew M., Wathen, Connor A., Ahluwalia, Manmeet S., Radivoyevitch, Tomas, Kornblum, Harley I., Kristensen, Bjarne W., Vogelbaum, Michael A., Lathia, Justin D.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Clinical Investigation 2018
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238746/
https://ncbi.nlm.nih.gov/pubmed/30385717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122264
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة